Literature DB >> 15864687

Eosinophilic fasciitis successfully treated with cyclosporine.

Aleksandra Bukiej1, Jerzy Dropiński, Grzegorz Dyduch, Andrzej Szczeklik.   

Abstract

We report on a 45-year-old female who developed eosinophilic fasciitis, characterized by scleroderma-like skin indurations, predominantly on the extremities and chest, with joint contractures and intermittent blood eosinophilia. Histologic examination revealed fibrosis of muscle fascia and eosinophilic infiltration. High-dose systemic corticosteroid therapy was ineffective, but cyclosporine treatment led to remission.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15864687     DOI： 10.1007/s10067-005-1099-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  17 in total

1.  Eosinophilic fasciitis following exposure to trichloroethylene: successful treatment with cyclosporin.

Authors:  N Hayashi; A Igarashi; T Matsuyama; S Harada
Journal:  Br J Dermatol       Date:  2000-04       Impact factor: 9.302

2.  Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis.

Authors:  Sabine-Gisela Plötz; Hans-Uwe Simon; Ulf Darsow; Dagmar Simon; Ekatherina Vassina; Shida Yousefi; Rüdiger Hein; Tim Smith; Heidrun Behrendt; Johannes Ring
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

3.  Cyclosporin A induced remission of CD4+ T-CLL associated with eosinophilia and fasciitis.

Authors:  P Laneuville
Journal:  Br J Haematol       Date:  1992-02       Impact factor: 6.998

4.  Cyclosporin in localized and systemic scleroderma--a clinical study.

Authors:  B Wörle; R Hein; T Krieg; M Meurer
Journal:  Dermatologica       Date:  1990

5.  Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporin.

Authors:  C J Fleming; P Clarke; D Kemmett
Journal:  Br J Dermatol       Date:  1997-02       Impact factor: 9.302

6.  Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis.

Authors:  C Romano; P Rubegni; G De Aloe; E Stanghellini; G D'Ascenzo; L Andreassi; M Fimiani
Journal:  J Eur Acad Dermatol Venereol       Date:  2003-01       Impact factor: 6.166

7.  Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: a new syndrome?

Authors:  L E Shulman
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

Review 8.  [Cyclosporin A in the therapy of inflammatory dermatoses].

Authors:  R U Peter; T Ruzicka
Journal:  Hautarzt       Date:  1992-11       Impact factor: 0.751

9.  Eosinophilic fasciitis (Shulman syndrome).

Authors:  Sandro Mosconi; Markus Streit; Marcel Brönimann; Lasse R Braathen
Journal:  Dermatology       Date:  2002       Impact factor: 5.366

10.  Cyclosporin A enhances cytokine and phorbol ester-induced fibroblast collagenase expression.

Authors:  J Lohi; V M Kähäri; J Keski-Oja
Journal:  J Invest Dermatol       Date:  1994-06       Impact factor: 8.551
View more
  12 in total

1.  Anti-neutrophil cytoplasmic antibody (c-ANCA) positive recurrent eosinophilic fasciitis responsive to cyclophosphamide: a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery.

Authors:  Virginia Florina Haiduc; Doruk Erkan; Kyriakos Kirou; Sherri Birchansky; Josephine Park; Moris J Danon
Journal:  HSS J       Date:  2007-12-18

2.  Eosinophilic fasciitis induced by fire ant bites.

Authors:  Jyothi R Mallepalli; Robert J Quinet; Rachana Sus
Journal:  Ochsner J       Date:  2008

3.  Infliximab may be effective in the treatment of steroid-resistant eosinophilic fasciitis: report of three cases.

Authors:  Dinesh Khanna; Harsh Agrawal; Philip J Clements
Journal:  Rheumatology (Oxford)       Date:  2010-03-22       Impact factor: 7.580

Review 4.  Eosinophilic fasciitis during pregnancy: case report and review of literature.

Authors:  Maria Ester Simeira Fonseca; Maria Victória Quaresma; Ana Paula Luppino-Assad; Henrique Carriço da Silva; Danieli Castro O Andrade; Percival D Sampaio-Barros
Journal:  Rheumatol Int       Date:  2017-12-15       Impact factor: 2.631

5.  Severe eosinophilic fasciitis: comparison of treatment with D-penicillamine plus corticosteroids vs. corticosteroids alone.

Authors:  F A Mendoza; R Bai; A G Kebede; S A Jimenez
Journal:  Scand J Rheumatol       Date:  2015-11-03       Impact factor: 3.641

Review 6.  Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment.

Authors:  Daniel R Mazori; Alisa N Femia; Ruth Ann Vleugels
Journal:  Curr Rheumatol Rep       Date:  2017-11-04       Impact factor: 4.592

Review 7.  Morphea and Eosinophilic Fasciitis: An Update.

Authors:  Jorre S Mertens; Marieke M B Seyger; Rogier M Thurlings; Timothy R D J Radstake; Elke M G J de Jong
Journal:  Am J Clin Dermatol       Date:  2017-08       Impact factor: 7.403

8.  Orthopedic considerations with eosinophilic fasciitis: a case report and literature review.

Authors:  Jason Samona
Journal:  Case Rep Orthop       Date:  2012-06-28

Review 9.  Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome.

Authors:  Yukie Endo; Atsushi Tamura; Youichiro Matsushima; Tomoko Iwasaki; Michiko Hasegawa; Yayoi Nagai; Osamu Ishikawa
Journal:  Clin Rheumatol       Date:  2007-03-08       Impact factor: 3.650

10.  Eosinophilic fasciitis: a case series with an emphasis on therapy and induction of remission.

Authors:  Rechelle Tull; William D Hoover; Jacqueline F De Luca; William W Huang; Joseph L Jorizzo
Journal:  Drugs Context       Date:  2018-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.